Cardiovascular Systems Inc Annual Cost of Revenue in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Cardiovascular Systems Inc quarterly/annual Cost of Revenue history and growth rate from 2017 to 2022.
  • Cardiovascular Systems Inc Cost of Revenue for the quarter ending December 31, 2022 was $18.5M, a 2.15% increase year-over-year.
  • Cardiovascular Systems Inc Cost of Revenue for the twelve months ending December 31, 2022 was $66.2M, a 1.21% decline year-over-year.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2022 was $63.4M, a 3.78% increase from 2021.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2021 was $61.1M, a 25.4% increase from 2020.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2020 was $48.8M, a 2.26% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $63.4M +$2.31M +3.78% Jul 1, 2021 Jun 30, 2022 10-K 2022-08-18
2021 $61.1M +$12.4M +25.4% Jul 1, 2020 Jun 30, 2021 10-K 2022-08-18
2020 $48.8M +$1.08M +2.26% Jul 1, 2019 Jun 30, 2020 10-K 2022-08-18
2019 $47.7M +$8.2M +20.8% Jul 1, 2018 Jun 30, 2019 10-K 2021-08-19
2018 $39.5M +$43K +0.11% Jul 1, 2017 Jun 30, 2018 10-K 2020-08-20
2017 $39.4M Jul 1, 2016 Jun 30, 2017 10-K 2019-08-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.